ArticleJournal of experimental & clinical cancer research : CR2024

FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A/STAT3 transcription mechanism.

Tian Yao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.